NEUROCME© Movement Disorders

Hosted by Patient Mind Inc. See our sustainability profile.
​A FREE Live Interactive CME Course Series with 130 Patient Videos | 6 CME Hours

Click Here for CME Credit

---

---

Seattle, WA
Saturday December 9, 2023
Hilton Bellevue
300 112th Avenue SE
​Bellevue, WA
LIVE IN-PERSON attendance only! 
Moderator: Pinky Agarwal, MD
​Register Now! Space is limited.

---

Sign-Up for Our Newsletter

---

​​Agenda and Topics
7:30-8:30 am - Breakfast & Registration
8:30-8:40 am - Welcome (Local Moderator)
8:40-9:40 am - Motor fluctuations in Parkinson’s disease;
detection & management (Dr. Dashtipour)
9:40-10:40 am – Deep brain stimulation for movement disorders (Dr. Tagliati)
10:40-11:00 am - Break
11:00-12:00 pm-An overview of drug induced movement disorders (Dr. Espay)
12:00-12:30 pm Chairman Video Round (Local Moderator)
12:30-1:20 pm - Lunch
1:20-2:20 pm - Utilization of Botulinum toxins for Movement Disorders (Dr. Tagliati)
2:20-3:20 pm - Non-motor features of Parkinson’s disease; diagnoses & treatment (Dr. Dashtipour)
3:20-3:30 pm Break
3:30-4:30 pm – Functional movement disorders (Dr. Espay)
4:30 pm - Closing Remarks (Local Moderator)

---

​CME Information
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Primary Care Network (PCN) and Patient Mind Inc. Primary Care Network is accredited by the ACCME to provide continuing medical education for physicians.
 
Primary Care Network designates this live activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

---

​Learning Objectives

1. Describe the clinical presentation and phenomenology associated with Parkinson’s Disease (PD) and other movement disorders.
2. Discuss the diagnostic approaches and tools available for PD and other movement disorders.
3. Identify and manage motor complications in PD such as moor fluctuations and dyskinesia.
4. List the relevant treatment options for PD and other movement disorders.
5. Evaluate surgical options and procedures available for PD and other movement disorders.
6. Discuss Deep Brain Stimulation (DBS), indications, contraindications, risks and benefits.
7. Evaluate the management of patients after DBS surgery.
8. Identify movement disorders that can be treated with botulinum toxin injections.
9. Describe the clinical presentation and phenomenology of tardive dyskinesia and other hyperkinetic movement disorders such as Huntington’s disease.
10. Discuss the treatment options to manage tardive dyskinesia and other hyperkinetic movement disorders.
11. Identify and management of non-motor features of PD and other movement disorders.

---

---